z-logo
open-access-imgOpen Access
Spry2 is a novel therapeutic target for periodontal tissue regeneration through fibroblast growth factor receptor signaling and epidermal growth factor signaling
Author(s) -
Terukazu Sanui,
Takao Fukuda,
Urara Tanaka,
Kyosuke Toyoda,
Takaharu Taketomi,
Fusanori Nishimura
Publication year - 2015
Publication title -
receptors and clinical investigation
Language(s) - English
Resource type - Journals
ISSN - 2330-0566
DOI - 10.14800/rci.597
Subject(s) - regeneration (biology) , epidermal growth factor , fibroblast growth factor , growth factor receptor inhibitor , microbiology and biotechnology , epidermal growth factor receptor , cancer research , fibroblast growth factor receptor 2 , fibroblast growth factor receptor , tissue repair , signal transduction , growth factor , receptor , biology , growth factor receptor , medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom